IP Library Granted Patent US 11,883,557
Granted Patent B2
US 11,883,557 · App. 17/662,462 · Granted Jan 30, 2024

Tunable, controlled-release, urethane-containing elastomers and processes of forming the same

Inventors: Stephanie Reed (Conshohocken, PA); Carissa Smoot (Harleysville, PA); Dennis Shull (Phoenixville, PA); Todd Crumbling (Perkasie, PA); John D'Ottavio (Telford, PA); Peter D. Gabriele (Frisco, TX); Jeremy J. Harris (Doylestown, PA); Charles Brendan Nicholson (Coopersburg, PA); Jared Ely (Quakertown, PA)
Assignee: THE SECANT GROUP, LLC
A61L27/18A61K31/522A61L27/54B29C67/246B33Y80/00B29C64/10B33Y10/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,883,557
App. No.
17/662,462
Granted
Jan 30, 2024
Kind
B2
Abstract

A process forms an implantable product including poly(glycerol sebacate) urethane (PGSU) loaded with an active pharmaceutical ingredient (API). The process includes homogeneously mixing a flowable poly(glycerol sebacate) (PGS) resin with the API and a catalyst to form a resin blend. The process also includes homogeneously combining the resin blend with an isocyanate to form a reaction mixture and injecting the reaction mixture to form the PGSU loaded with the API. An implantable product includes a PGSU loaded with an API. In some embodiments, the implantable product includes at least 40% w/w of the API, and the implantable product releases the API by surface degradation of the PGSU at a predetermined release rate for at least three months under physiological conditions. In some embodiments, the PGSU is formed from a PGS reacted with an isocyanate at an isocyanate-to-hydroxyl stoichiometric (crosslinking) ratio in the range of 1:0.25 to 1:1.25.

Claims (36)

1. A composition comprising poly(glycerol sebacate) urethane, wherein the poly(glycerol sebacate) urethane is formed from a poly(glycerol sebacate) resin reacted with an isocyanate at an isocyanate-to-hydroxyl stoichiometric ratio in the range of 1:0.25 to 1:1.25.

2. The composition of claim 1 , wherein the poly(glycerol sebacate) resin has a molecular weight greater than 10,000 Da.

3. The composition of claim 1 , wherein the poly(glycerol sebacate) resin has a polydispersity index less than 12.

4. The composition of claim 1 , wherein the poly(glycerol sebacate) resin has a glycerol-to-sebacic acid stoichiometric ratio of between 1:0.5 and 1:1.5.

5. The composition of claim 1 , wherein the isocyanate is a blocked isocyanate.

6. The composition of claim 1 , wherein the composition is free of a solvent.

7. The composition of claim 1 further comprising an active pharmaceutical ingredient mixed with the poly(glycerol sebacate) urethane, wherein the active pharmaceutical ingredient is at least 10% w/w of the composition.

8. The composition of claim 1 , wherein the isocyanate-to-hydroxyl stoichiometric ratio is in the range of 1:0.25 to 1:1.

9. The composition of claim 1 further comprising at least one additive mixed with the poly(glycerol sebacate) urethane, wherein the at least one additive is at least 10% w/w of the composition and the at least one additive is selected from the group consisting of an active pharmaceutical ingredient, a filler, and a combination thereof.

10. A composition comprising poly(glycerol sebacate) urethane, wherein the poly(glycerol sebacate) urethane is formed from a poly(glycerol sebacate) resin having a polydispersity index in the range of 8 to less than 12.

11. The composition of claim 10 , wherein the poly(glycerol sebacate) resin has a molecular weight greater than 10,000 Da.

12. The composition of claim 10 , wherein the poly(glycerol sebacate) resin has a glycerol-to-sebacic acid stoichiometric ratio of between 1:0.5 and 1:1.5.

13. The composition of claim 10 , wherein the isocyanate is a blocked isocyanate.

14. The composition of claim 10 , wherein the composition is free of a solvent.

15. The composition of claim 10 , wherein the isocyanate-to-hydroxyl stoichiometric ratio is in the range of 1:0.25 to 1:1.25.

16. The composition of claim 10 further comprising an active pharmaceutical ingredient mixed with the poly(glycerol sebacate) urethane, wherein the active pharmaceutical ingredient is at least 10% w/w of the composition.

17. A process of forming a poly(glycerol sebacate) urethane, the process comprising:

homogeneously mixing a flowable poly(glycerol sebacate) resin with a catalyst and a solvent to form a resin blend;

selecting an amount of isocyanate such that an isocyanate-to-hydroxyl stoichiometric ratio is in the range of 1:0.25 to 1:1.25;

homogeneously combining the resin blend with a composition comprising the isocyanate to form a reaction mixture; and

dispensing the reaction mixture to form the poly(glycerol sebacate) urethane.

18. The process of claim 17 , wherein the weight average molecular weight of the flowable poly(glycerol sebacate) resin is greater than 10,000 Da.

19. The process of claim 17 , wherein the homogeneously combining comprises mixing in a mixing chamber, a tip, or a nozzle.

20. The process of claim 17 , wherein the resin blend and the composition comprising the isocyanate are physically separated in a dual-barrel cartridge prior to the homogeneously combining.

21. The process of claim 17 , wherein the dispensing comprises spraying the reaction mixture through a spray coater nozzle.

22. The process of claim 17 , wherein the dispensing coats a substrate.

23. The process of claim 22 , wherein the substrate is a textile.

24. The process of claim 22 , wherein the dispensing comprises spraying the reaction mixture onto the substrate to spray coat the substrate.

25. The process of claim 17 , wherein the dispensing comprises spraying into air to form microparticles of the poly(glycerol sebacate) urethane.

26. A composition comprising poly(glycerol sebacate) urethane and an active pharmaceutical ingredient mixed with the poly(glycerol sebacate) urethane, wherein the poly(glycerol sebacate) urethane is formed from a poly(glycerol sebacate) resin reacted with an isocyanate at an isocyanate-to-hydroxyl stoichiometric ratio in the range of 1:0.25 to 1:5 and the active pharmaceutical ingredient mixed with the poly(glycerol sebacate) urethane is at least 40% w/w of the composition.

27. The composition of claim 26 , wherein the poly(glycerol sebacate) resin has a molecular weight greater than 10,000 Da.

28. The composition of claim 26 , wherein the poly(glycerol sebacate) resin has a polydispersity index less than 12.

29. The composition of claim 26 , wherein the poly(glycerol sebacate) resin has a glycerol-to-sebacic acid stoichiometric ratio of between 1:0.5 and 1:1.5.

30. The composition of claim 26 , wherein the isocyanate is a blocked isocyanate.

31. The composition of claim 26 , wherein the composition is free of a solvent.

32. A composition comprising poly(glycerol sebacate) urethane and at least one additive mixed with the poly(glycerol sebacate) urethane, wherein the poly(glycerol sebacate) urethane is formed from a poly(glycerol sebacate) resin reacted with an isocyanate at an isocyanate-to-hydroxyl stoichiometric ratio in the range of 1:0.25 to 1:5, the at least one additive is at least 40% w/w of the composition, and the at least one additive is selected from the group consisting of an active pharmaceutical ingredient, a filler, and a combination thereof.

Assignments (3)
SECURITY INTEREST Recorded Jun 20, 2025
From: THE SECANT GROUP, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 071473/0287 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2022
From: REED, STEPHANIE; SMOOT, CARISSA; SHULL, DENNIS; CRUMBLING, TODD; D'OTTAVIO, JOHN; GABRIELE, PETER D.; HARRIS, JEREMY J.; NICHOLSON, CHARLES BRENDAN; ELY, JARED
To: THE SECANT GROUP, LLC
Reel/Frame 059967/0908 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2022
From: REED, STEPHANIE; SMOOT, CARISSA; SHULL, DENNIS; CRUMBLING, TODD; D'OTTAVIO, JOHN; GABRIELE, PETER D.; HARRIS, JEREMY J.; NICHOLSON, CHARLES BRENDAN; ELY, JARED
To: THE SECANT GROUP, LLC
Reel/Frame 059869/0024 →
Continuity (5)
Continuation 17148130 · Jan 13, 2021
Continuation 16547175 · Aug 21, 2019
Provisional Application 62872793 · Jul 11, 2019
Provisional Application 62720412 · Aug 21, 2018
Related Publication 20220257828A1 · Aug 18, 2022
Cited By (2)
US 12,605,394 US 12,667,578